Clinical Trial Update: Stellate Ganglion Block for Major Depressive Disorder. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on stellate ganglion block as treatment for treatment-resistant depression and major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Stellate Ganglion Block

Snippet

Sponsor: Unity Health Toronto | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Status: COMPLETED